NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA NurExone’s Groundbreaking Exosome Therapies to be Showcased at Fall U.S. Conferences

NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility

Understanding Risk in Currency Carry Trade Strategies ROCHESTER, N.Y., March 8, 2016 (GLOBE NEWSWIRE) -- Whether you invest in stocks, bonds, commodities, or currencies, the carry trade is one of the most popular trading strategies in the currency...